The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...

The United States Food and Drug Administration (FDA) has approved a new non-opioid prescription medication, Journavx ...

A new painkiller that is said to be free of addiction risks may be transformative for treatment of acute pain, according to ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of ...

The opioid epidemic continues to affect hundreds of thousands of people, but there may be hope for the future with a new, non ...

That’s the opinion of top Vertex Pharmaceuticals executives and several market analysts about the Boston-based company’s painkiller Journavx, which the Food and Drug Administration approved on ...

The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...